research-articleIndian Journal of Pharmaceutical Education and ResearchVol. 58 | Issue 2s | 2024 | pp. s575–s581Open access
The Fast and Simple LC-MS/MS Method for Determination of Rifampicin in the Human Blood Plasma
- 1*,
- 1,
- 1,
- 1,
- 1,
- 2
- 1 Department of Pharmaceutical Analysis, Krupanidhi College of Pharmacy, Bangalore, Karnataka, INDIA.
- 2 Principal, Krupanidhi College of Pharmacy, Bangalore, Karnataka, INDIA.
Published in Indian Journal of Pharmaceutical Education and Research
Correspondence: V Baskaran
Department of Pharmaceutical Analysis, Krupanidhi College of Pharmacy, Bangalore, Karnataka, INDIA.
Email: chaithumpharm@gmail.com
Copyright: © 2024 Manuscript Technomedia. This is an open access article.
- Published:
- Jan 1, 2024
- Received:
- Feb 4, 2024
- Accepted:
- Mar 31, 2024
- DOI:
- 10.5530/ijper.58.2s.60
How to cite
Baskaran, V., Sudha, P. D. C., Abishek, T., Kumar, R. H., Ramesh, G., & Dang, R. (2024). The Fast and Simple LC-MS/MS Method for Determination of Rifampicin in the Human Blood Plasma. Indian Journal of Pharmaceutical Education and Research, 58(2s), s575–s581. https://doi.org/10.5530/ijper.58.2s.60
Abstract
Background
Rifampicin is an important anti tuberculosis drug for the early infection and, more importantly, bactericidal activity against mycobacterium tuberculosis. LC-MS/MS, with the required molecular specificity, provides quantitative method to rapidly differentiate between the drugs and their metabolites.
Aim
The current study represents the fast and simple LC-MS/MS method for determination of rifampicin in the human blood plasma.
Materials and Methods
The plasma samples containing the rifampicin drug were cleaned up by using the protein precipitation method. The chromatographic division was performed by utilizing the ZORBAX Eclipse plus C18 Column (4.6 mm X 150 mm, 5μm). The versatile stage comprised of acetonitrile and 10 Mm ammonium acetic acid derivation in a proportion of 80:20% V/V, wash the column with the blend of solvents comprising of acetonitrile and water 80:20% V/V, maintaining column oven temperature at 30°C±1°C and the auto sampler temperature is kept up with at 10°C±1°C. The injection volume of the sample is 10.0 μL and the total run time of the experiment is 4 min with a flow rate of 1000 mL/min and with a split ratio of 50:50 for the entire experiment.
Results and Discussion
An LC-MS/MS method for the rifampicin from the sample was performed. Sample volume of 0.300 ml, the injection volume is taken as 10.0 μL and total run time is 4 min, RT for rifampicin is 1.30±0.5 min and the reference drug roxithromycin RT is 3.00±0.5 min.
Conclusion
The transient LC-MS/MS study permits the assessment of enormous quantities of blood tests in a brief timeframe with fast, simple and successful readiness, giving a quick, dependable and best device for RIF clinical observing and review.
Keywords
Subject
Article metadata
| Title | The Fast and Simple LC-MS/MS Method for Determination of Rifampicin in the Human Blood Plasma |
|---|---|
| Authors | V Baskaran; P. D. Chaithanya Sudha; T Abishek; R Hariesh Kumar; G Ramesh; Raman Dang |
| Affiliations | Department of Pharmaceutical Analysis, Krupanidhi College of Pharmacy, Bangalore, Karnataka, INDIA.; Principal, Krupanidhi College of Pharmacy, Bangalore, Karnataka, INDIA. |
| Corresponding author | chaithumpharm@gmail.com |
| Journal | Indian Journal of Pharmaceutical Education and Research |
| Volume / Issue | Vol. 58, Issue 2s (2024) |
Also in this issue
- Clinical Efficacy and Safety of Ceftriaxone in Surgical Prophylaxis: A Systematic Review and Meta-Analysispp. s332–s339
- Effectiveness of Complementary and Alternative Medicine and Physical Therapies in Peripheral Arterial Disease with Intermittent Claudication: A Systematic Reviewpp. s340–s353
- Implementation of National Education Policy 2020 in Pharmacy Educationpp. s354–s358
- A Biochemical and Molecular Insight to Wound Healing Properties of Traditional Indian Medicines in Normal and Diabetic Ratspp. s359–s371
- Chlorogenic Acid, a Potential Glucose-6-Phosphatase Inhibitor: An Approach to Develop a Pre-Clinical Glycogen Storage Disease Type I Modelpp. s372–s381